Ocugen
Price & Volume
Stats
See more52W Range | $0.69-$2.72 |
Market Cap | $238.2M |
Shares Short | 107M |
Financials
See moreRevenue (12 Mos) | $4.5M |
Revenue Growth (YoY) | 8.4% |
Gross Profit (12 Mos) | -$39.1M |
Diluted EPS | -$0.26 |
News
See moreYahoo Finance • last month
Retinitis Pigmentosa Market Outlook to Strengthen During the Forecast Period (2026-2036) with Growing Focus on Disease-Modifying Therapies | DelveInsight
Yahoo Finance • last month
Sector Update: Healthcare Stocks Edge Higher in Afternoon Trading
Yahoo Finance • 2 months ago
Ocugen slips after interim trial data for Stargardt disease candidate
Yahoo Finance • 3 months ago
Ocugen (OCGN) Q2 2026 Earnings Call Transcript
About
CEO | Dr. Shankar Musunuri M.B.A., Ph.D. |
CFO | Ms. Rita Johnson-Greene M.B.A. |
Address | 11 Great Valley Parkway, Malvern, PA, United States, 19355 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 116 |